Evaluation of the efficacy of naratriptan for the treatment and prevention of post traumatic headache associated with cognitive dysfunction.

Trial Profile

Evaluation of the efficacy of naratriptan for the treatment and prevention of post traumatic headache associated with cognitive dysfunction.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 08 Feb 2013

At a glance

  • Drugs Naratriptan (Primary)
  • Indications Headache
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Feb 2010 Actual patient number (12) added as reported by ClinicalTrials.gov.
    • 09 Feb 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 10 Sep 2009 Planned end date changed from 1 Nov 2009 to 1 Oct 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top